Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) (Parenthetical)

v3.24.1
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) (Parenthetical) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
potentially dilutive shares 988,773 1,075,051    
Common Stock [Member]        
Conversion price     $ 3.50 $ 6.40
Series B Preferred Stock [Member]        
Conversion price $ 5.30      
Debt instrument, convertible, stock price trigger $ 3.00      
potentially dilutive shares 654,696      
Series B Preferred Stock [Member] | Common Stock [Member]        
Common stock issued 658,968